Redefining Curative-Intent Treatment for Colorectal Liver Metastases: Surgical and Multidisciplinary Decision-Making—A Systematic Review
Livers · 01.11.2026 · 6 (6) · 112
DOI: 10.3390/livers6060112 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Livers, online erschienen am 01.11.2026. Verfasst von Pipit Burasakarn und 5 weiteren Autor:innen. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Treatment of colorectal liver metastases (CRLM) has shifted from a surgery-centered to a multidisciplinary, biology-driven approach, and surgical decisions have become more individualized.
Methods
Following PRISMA 2020, PubMed/MEDLINE was searched (January 1995–September 2026), supplemented by citation and guideline searching, for randomized trials, systematic reviews, guidelines, and large prospective or registry studies of adults with CRLM; findings were synthesized narratively by review question.
Results
Of 1072 database records screened and 76 reports from other sources, 102 studies were included. Thermal ablation was non-inferior to resection for metastases ≤ 3 cm in the randomized COLLISION trial, with fewer adverse events (19% versus 46%). Parenchymal-sparing and minimally invasive hepatectomy, liver-remnant modulation (portal vein embolization, ALPPS), and repeat local treatment widened surgical eligibility, and sidedness- and genotype-guided conversion therapy increased secondary resection. Simultaneous, staged, and liver-first sequencing achieved similar survival in selected patients. Transplantation improved survival over chemotherapy alone in permanently unresectable, liver-confined disease. Certainty of evidence was lowest for surgical technique and patient selection.
Conclusions
Curative-intent treatment should be planned lesion by lesion by a multidisciplinary team, combining resection and ablation according to tumor biology, anatomy, liver reserve, and patient fitness. Patient-reported outcomes and equitable access remain poorly studied.
Zitieren
APA
Burasakarn, P., Ponghussaban, K., Chalokool, V., Thienhiran, A., Hongjinda, S., & Fuengfoo, P. (2026). Redefining Curative-Intent Treatment for Colorectal Liver Metastases: Surgical and Multidisciplinary Decision-Making—A Systematic Review. Livers, 6(6), 112. https://doi.org/10.3390/livers6060112
Vancouver
Burasakarn P, Ponghussaban K, Chalokool V, Thienhiran A, Hongjinda S, Fuengfoo P. Redefining Curative-Intent Treatment for Colorectal Liver Metastases: Surgical and Multidisciplinary Decision-Making—A Systematic Review. Livers. 2026;6(6):112. doi:10.3390/livers6060112
BibTeX
@article{Burasakarn2026,
author = {Burasakarn, Pipit and Ponghussaban, Kanokkarn and Chalokool, Vachiraluck and Thienhiran, Anuparp and Hongjinda, Sermsak and Fuengfoo, Pusit},
title = {Redefining Curative-Intent Treatment for Colorectal Liver Metastases: Surgical and Multidisciplinary Decision-Making—A Systematic Review},
journal = {Livers},
year = {2026},
volume = {6},
number = {6},
pages = {112},
doi = {10.3390/livers6060112}
}
EUVIMED